NLS Pharmaceutics AG

1.48
-0.01 (-0.67%)
At close: Apr 04, 2025, 10:50 AM

NLS Pharmaceutics AG Statistics

Share Statistics

NLS Pharmaceutics AG has 2.47M shares outstanding. The number of shares has increased by -94.3% in one year.

Shares Outstanding 2.47M
Shares Change (YoY) -94.3%
Shares Change (QoQ) 0%
Owned by Institutions (%) 22.34%
Shares Floating 1.57M
Failed to Deliver (FTD) Shares 935
FTD / Avg. Volume 0.04%

Short Selling Information

The latest short interest is 85.78K, so 3.47% of the outstanding shares have been sold short.

Short Interest 85.78K
Short % of Shares Out 3.47%
Short % of Float 5.26%
Short Ratio (days to cover) 0.04

Valuation Ratios

The PE ratio is -73.77 and the forward PE ratio is -3.42. NLS Pharmaceutics AG's PEG ratio is 1.19.

PE Ratio -73.77
Forward PE -3.42
PS Ratio 0
Forward PS 0
PB Ratio -101.65
P/FCF Ratio -92.72
PEG Ratio 1.19
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NLS Pharmaceutics AG.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.23, with a Debt / Equity ratio of -0.18.

Current Ratio 0.23
Quick Ratio 0.23
Debt / Equity -0.18
Debt / EBITDA -0.14
Debt / FCF -0.17
Interest Coverage -81.34

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.03M
Employee Count 6
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -76.18% in the last 52 weeks. The beta is -0.22, so NLS Pharmaceutics AG's price volatility has been lower than the market average.

Beta -0.22
52-Week Price Change -76.18%
50-Day Moving Average 1.81
200-Day Moving Average 4.3
Relative Strength Index (RSI) 42.36
Average Volume (20 Days) 2.39M

Income Statement

Revenue n/a
Gross Profit -11.41K
Operating Income -11.81M
Net Income -12.17M
EBITDA -11.8M
EBIT -11.81M
Earnings Per Share (EPS) -0.32
Full Income Statement

Balance Sheet

The company has 897.68K in cash and 1.63M in debt, giving a net cash position of -736.07K.

Cash & Cash Equivalents 897.68K
Total Debt 1.63M
Net Cash -736.07K
Retained Earnings -70.37M
Total Assets 1.19M
Working Capital -6.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.68M and capital expenditures -4, giving a free cash flow of -9.68M.

Operating Cash Flow -9.68M
Capital Expenditures -4
Free Cash Flow -9.68M
FCF Per Share -0.25
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NLSP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NLSP.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Sep 27, 2024. It was a backward split with a ratio of 1:40.

Last Split Date Sep 27, 2024
Split Type backward
Split Ratio 1:40

Scores

Altman Z-Score -148.52
Piotroski F-Score 1